Key factors to consider when measuring multimorbidity: Results from an expert panel and online survey.
Key factors to consider when measuring multimorbidity: Results from an expert panel and online survey.
复制标题
DOI：
10.1177/2235042x18795306
复制
发表时间：
2018-01
影响因子：
--
通讯作者：
Upshur R
中科院分区：
文献类型：
--
作者：
Griffith LE;Gruneir A;Fisher KA;Nicholson K;Panjwani D;Patterson C;Markle-Reid M;Ploeg J;Bierman AS;Hogan DB;Upshur R
目前有多种多样的多重标准措施，但对于哪些措施最适合不同的情况却没有达成共识。与老龄化研究和多重死亡率领域的专家就衡量多重死亡率时应考虑的关键因素进行讨论，分享从中获得的见解。描述性研究的专家意见的多项措施，通过文献资料，以确定可用的措施，然后是一个面对面的会议和在线调查。该专家组包括加拿大的临床医生、研究人员和政策制定者，他们在多发病和老龄化领域具有专门知识。在受邀的30名专家中，15名（50%）出席了现场会议，14名（47%）对随后的在线调查作出了答复。专家们一致认为，没有一种单一的多重标准适合于所有的研究。他们列举了在选择用于研究的测量方法时需要考虑的一些因素，包括：（1）与研究目的的契合度;（2）多重测量方法中包含的条件;（3）偶发性条件或疾病的作用;以及（4）社会因素的作用和现有方法中缺失的其他概念。现有的多变量测量方法是否适合用于特定的研究，取决于研究目的、研究结果和相关利益相关者的偏好等因素。这项研究的结果表明，有一些领域需要进一步建设的概念化和测量多morphine的未来的临床，研究和政策决策的好处。
There are multiple multimorbidity measures but little consensus on which measures are most appropriate for different circumstances. To share insights gained from discussions with experts in the fields of ageing research and multimorbidity on key factors to consider when measuring multimorbidity. Descriptive study of expert opinions on multimorbidity measures, informed by literature to identify available measures followed by a face-to-face meeting and an online survey. The expert group included clinicians, researchers and policymakers in Canada with expertise in the fields of multimorbidity and ageing. Of the 30 experts invited, 15 (50%) attended the in-person meeting and 14 (47%) responded to the subsequent online survey. Experts agreed that there is no single multimorbidity measure that is suitable for all research studies. They cited a number of factors that need to be considered in selecting a measure for use in a research study including: (1) fit with the study purpose; (2) the conditions included in multimorbidity measures; (3) the role of episodic conditions or diseases; and (4) the role of social factors and other concepts missing in existing approaches. The suitability of existing multimorbidity measures for use in a specific research study depends on factors such as the purpose of the study, outcomes examined and preferences of the involved stakeholders. The results of this study suggest that there are areas that require further building out in both the conceptualization and measurement of multimorbidity for the benefit of future clinical, research and policy decisions.